USFDA approves Lupin’s generic version of HIV/AIDS tablets | The Financial Express

USFDA approves Lupin’s generic version of HIV/AIDS tablets

Darunavir is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.

USFDA approves Lupin’s generic version of HIV/AIDS tablets
The product will be manufactured at Lupin’s facility in Nagpur, India. (File)

Global pharma major Lupin Limited on Tuesday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Darunavir Tablets, 600 mg and 800 mg.

It is a generic equivalent of Prezista Tablets of Janssen Products, LP. According to the company, Lupin is the exclusive first filer for 800 mg tablets and is eligible for 180-day exclusivity.

Moreover, Lupin will also potentially have shared 180-day exclusivity on the 600 mg tablets. The product will be manufactured at Lupin’s facility in Nagpur, India.

Darunavir Tablets, 600 mg and 800 mg, (RLD Prezista) had estimated annual sales of USD 343 million in the U.S. (IQVIA MAT June 2022).

Darunavir is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. According to experts, it is often used with low doses of ritonavir or cobicistat to increase darunavir levels.

ALSO READ | Lupin gets EIR from US FDA for its Ankleshwar Manufacturing Facility

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Photos
7 Photos
Assembly Election Results 2022: BJP’s celebratory dance in Gujarat, Congress exudes confidence in Himachal – See Photos
10 Photos
Realme 10 Pro Plus launched in India: The 10-point rough cut
9 Photos
AAP sweeps away 15 year BJP reign in MCD election – Photos from celebrations